Bangma Chris, Obbink Henk
Department of Urology, Erasmus University Medical Centre, Rotterdam, The Netherlands.
Transl Androl Urol. 2018 Feb;7(1):188-194. doi: 10.21037/tau.2017.12.32.
The use of digital data in large data sets will be of pivotal importance to unravel the biological basis of prostate cancer, and to improve on prevention and treatment. For the screening of asymptomatic tumors, their identification, and their treatment with better and targeted therapies, the integration of information from imaging, genomics, and biomarkers is needed. To bring these (un)structured data together, block chain technology is required, while knowledgeable analysts should be available. Therefore, it is of utmost importance to 'team up' and provide a common strategy for innovation. Its implementation needs the involvement of all stakeholders (patients, industries, professionals, scientists, governments). This article provides thoughts on how initial steps in urology have been taken, and how to proceed.
在大数据集中使用数字数据对于揭示前列腺癌的生物学基础以及改善预防和治疗至关重要。对于无症状肿瘤的筛查、识别以及采用更好的靶向疗法进行治疗，需要整合来自影像学、基因组学和生物标志物的信息。为了将这些（非）结构化数据整合在一起，需要区块链技术，同时要有知识渊博的分析师。因此，“携手合作”并提供共同的创新策略至关重要。其实施需要所有利益相关者（患者、行业、专业人士、科学家、政府）的参与。本文就泌尿外科已采取的初步措施以及如何继续推进提供了思路。
